OUTPATIENT CANCER PATIENTS: THE RELATIONSHIP BETWEEN INFORMATION OVERLOAD, SYMPTOM SEVERITY, AND EMPOWERMENT LEVEL
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Oncologic Disease. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Examining the relationship between information load, symptom severity, and empowerment level in outpatient cancer patients is of great importance for developing holistic care plans tailored to the individual needs of patients and for planning supportive interventions in oncology nursing.
Primary outcome measures
- Relationship Between Information Burden, Symptom Management, and Empowerment Levels in Patients Receiving Outpatient Chemotherapy [Time frame: 01.07.2026-01.20.2026]
- Information burden, symptom severity, and reinforcement level in outpatient chemotherapy patients [Time frame: 01.07.2026--01.10.2026]
Eligibility criteria
Inclusion Criteria: Eligibility criteria include having a clinical diagnosis of cancer, having received at least one course of outpatient chemotherapy, and being 18 years of age or older.
\-
Exclusion Criteria: The criteria for eligibility include having a severe mental disorder that could affect the patient's perception and responses, it being the first day of treatment, and the patient being under 18 years of age.
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Center list to be confirmed — check the primary protocol.
Publications
- Yilmaz Karabulutlu E, Bahcecioglu Turan G, Karaman S. Turkish Validity and Reliability Study of Cancer Empowerment Scale. Psychiatr Danub. 2021 Dec;33(Suppl 13):314-320. PMID 35150501
- Yildirim Y, Tokem Y, Bozkurt N, Fadiloglu C, Uyar M, Uslu R. Reliability and validity of the Turkish version of the Memorial Symptom Assessment Scale in cancer patients. Asian Pac J Cancer Prev. 2011;12(12):3389-96. PMID 22471486
- Tanrıkut, R., Koç, A. (2023). Son 10 yılda hemşirelik alanında semptom yönetimi konulu yüksek lisans ve doktora tezlerin retrospektif incelenmesi. Medical Research Reports, 6(3), 164-182
- Sezgin, M. G., Bektaş, H. (2022). Multipl myelom hastalarında güncel tedavi önerileri ve semptom yönetimi. Ege Üniversitesi Hemşirelik Fakültesi Dergisi, 38(1), 49-59.
- Seven M, AKYÜZ A, Sever N, Dinçer Ş (2013). Kanser tanısı alan hastaların yaşadığı fiziksel ve psikolojik semptomların belirlenmesi. TAF Prev Med Bull 12(3):219-224.
- Pehlivan, Z., Gülhan Güner, S., Nural, N. (2022). Kanser hastalarında bir semptom konstipasyon: Literatür incelemesi. İzmir Kâtip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 7(1), 139-144.
- Pekmezci, H., Genç Köse, B., Akbal, Y., Aşık Özdemir, V., Kefeli Çol, B. (2022). Kemoterapi alan kanser hastalarının semptom yönetiminde tamamlayıcı terapi kullanımları. Sağlık Akademisyenleri Dergisi, 9(3), 211-219.
- Öztoprak, F. S., Ege, E. (2021). Kadın işçilerin kanser bilgi yükü ile sağlıklı yaşam biçimi davranışları ilişkisinin incelenmesi. Ege Üniversitesi Hemşirelik Fakültesi Dergisi, 37(2), 141-156.
Identifiers
NCT: NCT07667881 · 2026-125